Keywords: arris, promising, data, asthma, drug, pharmaceutical, released

Arris' Promising Data With Asthma Drug

Article | 30 September 1996

Print This

Arris Pharmaceutical has released the final data from its Phase IIa clinical trial with its tryptase inhibitor, APC-366, for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in